| Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B (NCT03429439) | Zhongshan Hospital Xiamen University | 2017-12-29 |
| Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF (NCT03356834) | Humanity and Health Research Centre | 2017-12-01 |
| Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy (NCT05451420) | Henan Provincial People's Hospital | 2017-12-01 |
| Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B (NCT03349008) | Cttq | 2017-11-25 |
| A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B (NCT05282407) | Samjin Pharmaceutical Co., Ltd. | 2017-11-20 |
| The Effect of Entecavir Consolidation on Post-TDF Treatment Durability (NCT03308890) | Taipei Veterans General Hospital, Taiwan | 2017-11-01 |
| Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir. (NCT03241641) | Young-Suk Lim | 2017-10-26 |
| Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal (NCT03215732) | ANRS, Emerging Infectious Diseases | 2017-10-19 |
| The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection (NCT03253250) | Huashan Hospital | 2017-09-01 |
| A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients (NCT03244085) | Qilu Pharmaceutical Co., Ltd. | 2017-08-20 |
| The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules (NCT03638076) | Sunshine Lake Pharma Co., Ltd. | 2017-07-26 |
| IL-35+Breg/Il-35 Effect on T Cell Immune in Patients With CHB (NCT03734783) | Changhai Hospital | 2017-07-01 |
| Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) (NCT03180619) | Gilead Sciences | 2017-06-29 |
| Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B (NCT03109730) | Assembly Biosciences | 2017-06-15 |
| A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo (NCT03642340) | IlDong Pharmaceutical Co Ltd | 2017-05-15 |
| Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients (NCT04646928) | CHA University | 2017-03-17 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B (NCT03038113) | Hoffmann-La Roche | 2017-02-06 |
| Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers (NCT03032536) | Alios Biopharma Inc. | 2017-01-31 |
| The Study of Short-range Antiviral Treatment During Pregnancy to Block Mother-to-child Transmission of Hepatitis B Virus and Withdrawal Time (NCT03209908) | Beijing Ditan Hospital | 2017-01-01 |
| Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBV (NCT03181607) | Xingfei Pan | 2017-01-01 |
| The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus Infection (NCT03214302) | Beijing Ditan Hospital | 2017-01-01 |
| Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed (NCT02979613) | Gilead Sciences | 2016-12-29 |
| Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B (NCT04069858) | Korea University | 2016-12-01 |
| Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers (NCT02991638) | The University of Hong Kong | 2016-11-01 |
| Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection (NCT02932150) | Gilead Sciences | 2016-11-01 |
| A Study in Healthy Volunteers and Patients With Chronic Hepatitis B (NCT02908191) | Assembly Biosciences | 2016-11-01 |
| Effect of Polyherbal Formulation in Chronic Inactive Carriers of Hepatitis B Virus (NCT02899130) | Composite Interceptive Med Science | 2016-10-01 |
| Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant (NCT02862548) | Gilead Sciences | 2016-09-16 |
| Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients (NCT02793791) | Shandong Cancer Hospital and Institute | 2016-09-01 |
| HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection Patients (NCT02908763) | Third Affiliated Hospital, Sun Yat-Sen University | 2016-08-01 |
| Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB Infection (NCT02886182) | Beijing Ditan Hospital | 2016-08-01 |
| Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease (NCT02863757) | Humanity and Health Research Centre | 2016-08-01 |
| A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection (NCT02826018) | Alnylam Pharmaceuticals | 2016-06-24 |
| The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg (NCT02838810) | Third Affiliated Hospital, Sun Yat-Sen University | 2016-06-01 |
| Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet (NCT02805738) | Chong Kun Dang Pharmaceutical | 2016-04-01 |
| Off-therapy Response After Stopping Entecavir or Tenofovir (NCT03042481) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2016-04-01 |
| Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B (NCT02774837) | Seng Gee Lim | 2016-04-01 |
| The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg (NCT02745704) | Third Affiliated Hospital, Sun Yat-Sen University | 2016-04-01 |
| REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection (NCT02565719) | Replicor Inc. | 2016-03-01 |
| Off Treatment Durability in Chronic Hepatitis B With Good Immune Control (NCT02738554) | The University of Hong Kong | 2016-01-01 |
| Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection (NCT02973646) | Third Affiliated Hospital, Sun Yat-Sen University | 2016-01-01 |
| Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy (NCT03366571) | Beijing Friendship Hospital | 2016-01-01 |
| Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients (NCT03332329) | Qin Ning | 2015-12-01 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated (NCT02579382) | Gilead Sciences | 2015-11-10 |
| A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB (NCT02615639) | Third Affiliated Hospital, Sun Yat-Sen University | 2015-11-01 |
| Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet (NCT02589457) | Chong Kun Dang Pharmaceutical | 2015-10-01 |
| Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy (NCT02594293) | Huashan Hospital | 2015-10-01 |
| Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B (NCT02533544) | Myeong Jun Song | 2015-10-01 |
| Safety and Tolerability of TG1050: A Dose-finding Study (NCT02428400) | Transgene | 2015-10-01 |
| The Establishment of Korean Hepatitis B Patients Cohort (NCT04139850) | Yonsei University | 2015-09-25 |
| Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (NCT02452528) | Arrowhead Pharmaceuticals | 2015-08-01 |
| Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B (NCT02532413) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2015-07-01 |
| A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High Risk (NCT02901418) | Beijing Ditan Hospital | 2015-07-01 |
| The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study (NCT01831037) | University of Arkansas | 2015-07-01 |
| Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues (NCT02792088) | IlDong Pharmaceutical Co Ltd | 2015-07-01 |
| An Exploratory Study of RGT Strategy on Optimal NUC-experienced Patients (NCT02560649) | Ruijin Hospital | 2015-05-01 |
| Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy (NCT02505009) | Chang Gung Memorial Hospital | 2015-05-01 |
| Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) Adults (NCT02822547) | Yonsei University | 2015-03-01 |
| Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment (NCT02364336) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-02-14 |
| Study of ARC-520 in Patient With Chronic Hepatitis B Virus (NCT02349126) | Arrowhead Pharmaceuticals | 2015-02-01 |
| Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients (NCT02401737) | Novira Therapeutics, Inc. | 2015-01-31 |
| Impact of Fatty Liver on Hepatitis B Therapy (NCT06535048) | Tianjin Second People's Hospital | 2015-01-01 |
| Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude (NCT02523547) | Hanmi Pharmaceutical Company Limited | 2015-01-01 |
| A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB (NCT01935635) | Third Affiliated Hospital, Sun Yat-Sen University | 2015-01-01 |
| Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B (NCT02463019) | E-DA Hospital | 2015-01-01 |
| Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection (NCT02258581) | Gilead Sciences | 2014-12-09 |
| Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B (NCT02249988) | Abivax S.A. | 2014-12-01 |
| Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection (NCT02355951) | Transgene | 2014-12-01 |
| Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers (NCT02300688) | IlDong Pharmaceutical Co Ltd | 2014-12-01 |
| Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection (NCT02058108) | Novartis Pharmaceuticals | 2014-10-31 |
| Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis B (NCT02263755) | Yonsei University | 2014-09-02 |
| Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B (NCT02287857) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2014-09-01 |
| Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive Patients (NCT02474316) | Ruijin Hospital | 2014-08-01 |
| Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background (NCT02053727) | University of California, Los Angeles | 2014-07-01 |
| Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants (NCT02166047) | Gilead Sciences | 2014-06-30 |
| A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B (NCT02332473) | Xiamen Amoytop Biotech Co., Ltd. | 2014-06-01 |
| Observational Study on Patients With Chronic Hepatitis B (NCT02167503) | Nanfang Hospital, Southern Medical University | 2014-05-01 |
| FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis (NCT02476695) | Wuxi Hisky Medical Technology Co Ltd | 2014-05-01 |
| Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients (NCT02112799) | Novira Therapeutics, Inc. | 2014-04-30 |
| Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy (NCT02056548) | Seoul St. Mary's Hospital | 2014-03-01 |
| Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b (NCT02883647) | Third Affiliated Hospital, Sun Yat-Sen University | 2014-01-01 |
| Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy (NCT01928511) | Seng Gee Lim | 2014-01-01 |
| Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV Infection (NCT02017587) | Vaccine and Gene Therapy Institute, Florida | 2013-12-01 |
| Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases (NCT02049736) | Chinese University of Hong Kong | 2013-12-01 |
| Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation (NCT02125071) | Dong-Gu Kim | 2013-11-01 |
| Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients (NCT01997944) | Beijing Bio-Fortune Ltd. | 2013-11-01 |
| Phase 3 and Extensional Study of Besifovir (NCT01937806) | IlDong Pharmaceutical Co Ltd | 2013-10-01 |
| A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial (NCT01965418) | Beijing 302 Hospital | 2013-09-01 |
| Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues (NCT01911156) | University Health Network, Toronto | 2013-07-01 |
| The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion (NCT01878565) | Beijing 302 Hospital | 2013-06-01 |
| HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance (NCT01769833) | Pusan National University Hospital | 2013-05-01 |
| Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir (NCT01711567) | Korea University | 2013-04-01 |
| 3E Extension Study (NCT01834508) | Nanfang Hospital, Southern Medical University | 2013-03-01 |
| Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B (NCT01760122) | Xiamen Amoytop Biotech Co., Ltd. | 2013-03-01 |
| Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy (NCT01829685) | Nanfang Hospital, Southern Medical University | 2013-03-01 |
| Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg (NCT01817725) | Chang Gung Memorial Hospital | 2013-03-01 |
| Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E (NCT01813487) | Genexine, Inc. | 2013-02-01 |
| Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in Korea (NCT01776814) | Gachon University Gil Medical Center | 2013-02-01 |
| Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B (NCT01925820) | National Taiwan University Hospital | 2013-01-01 |
| Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment (NCT02365402) | Beijing Ditan Hospital | 2013-01-01 |